Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Liabilities from Discontinued Operations (2022)

Bioventus (BVS) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 119087000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 119087000.0, compared with a TTM value of 119087000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of 119087000.0, changed N/A over the prior year.
  • Liabilities from Discontinued Operations was 119087000.0 for Q4 2022 at Bioventus.
  • Across five years, Liabilities from Discontinued Operations topped out at 119087000.0 in Q4 2022 and bottomed at 119087000.0 in Q4 2022.